We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Diagnosing a deal

7 February 2011 By Lisa Lee

Danaher has snatched medical group Beckman Coulter, outbidding buyout firms in the process. It shows that despite relatively easy credit, private equity isn’t the only acquirer that can pay up. But the acquisitive Danaher isn’t your typical strategic buyer, either.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)